Back to Treatments

Treatment

Bedaquiline + Pretomanid + Linezolid + Moxifloxacin (BPaLM Regimen)

1
Conditions
15
Trials
1,500
Participants
36%
Average Safety

Condition Evidence

HIV/AIDS - Extensively drug-resistant Tuberculosis

15 trials · 1,500 participants

89% effectiveness · 36% safety
Bedaquiline + Pretomanid + Linezolid + Moxifloxacin (BPaLM Regimen) | DFDA